Mineralys Therapeutics In... (MLYS)

MLYS trades at $38.06, 8.7% above the near-term max pain of $35 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($20-$40), reflecting growing call interest at higher strikes. Key magnetic zone at 40 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for MLYS shows an upward trend from 20 to 40, suggesting bullish positioning in longer-dated options. The 63% spread signals divergent expectations across timeframes. Levels distributed around 38.06. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.